<DOC>
	<DOCNO>NCT00264082</DOCNO>
	<brief_summary>The purpose research study evaluate usefulness TRAP protein ( 1 ) early indicator bone destruction ( 2 ) tool assess effect Zometa® treating symptom bone metastasis due breast cancer . Tartrate-resistant acid phosphatase ( TRAP ) protein release blood stream result bone destruction cause metastasis breast cancer bone . Bone destruction cause pain bone fracture . This study measure TRAP level serum take breast cancer patient see TRAP level able predict effect Zometa® treatment bone destruction , pain bone fracture .</brief_summary>
	<brief_title>Assessment Tartrate-Resistant Acid Phosphatase ( TRAP ) Bone Resorption Marker Stage IV Breast Cancer Patients With Bone Metastasis</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bone Resorption</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<criteria>1 . Histologic cytologic documentation breast cancer . 2 . Stage IV Breast Cancer Patients bone metastasis Zometa treatment initiate . 3 . Age &gt; 18 4 . Written inform consent prior study entry 5 . Patients may currently receive hormone therapy , chemotherapy and/or radiation therapy primary tumor . 6 . Life expectancy least 6 month . 7 . We include patient previous current radiation therapy breast 1 . Concurrent malignancy second primary 2 . Stage I , Stage II Stage III 3 . ECOG Performance Status 3 4 . 4 . Renal Failure serum creatinine &gt; 2.O mg/dL screen 5 . AST ALT &gt; ULN X 3. screen 6 . Bilirubin &gt; 3.0 mg/dL screen 7 . Pregnant woman 8 . Prior current bisphosphonate therapy 9 . Any skeletal related event due malignancy prior study enrollment . 10 . Patients osteoporotic fracture prior study enrollment . 11 . Allergy bisphosphonates 12 . Any radiation therapy treatment bone metastases &lt; 4 week prior study start . 13 . Any chronic medical condition would preclude performance adherence protocol requirement 14 . Inability provide inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>